Novartis Investigative Site

Blois 41016

0 studies enrolling now · 3 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic, Multiple Myeloma, Primary Immune Thrombocytopenia

Studies at this site

• A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids — Running, not enrolling
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early